Back to Results
First PageMeta Content
Biology / Extensively drug-resistant tuberculosis / Tuberculosis treatment / TBVI / TB Alliance / Multi-drug-resistant tuberculosis / Stop TB Partnership / Mario Raviglione / Alimuddin Zumla / Tuberculosis / Medicine / Health


Drug-resistant tuberculosis in the European Union: Opportunities and challenges for control
Add to Reading List

Document Date: 2013-02-28 06:03:55


Open Document

File Size: 162,47 KB

Share Result on Facebook

City

Moscow / Hospital / Paris / The Hague / Bilthoven / Vienna / Tartu / Geneva / Parida / Leopoldina / Warsaw / Boston / Medical Center / Berlin / London / Brussels / /

Company

PAN-NET / The Stop TB Partnership / Ó 2010 Elsevier Ltd. / FIND Diagnostics / NIAID Tuberculosis Working Group / Reference Laboratories / EASAC Working Group / Treatment Action Group / /

Continent

Europe / Africa / Asia / /

Country

Switzerland / Netherlands / Estonia / France / United Kingdom / China / Finland / India / Germany / Sweden / Poland / Belgium / Russia / Austria / United States / Soviet Union / Spain / /

Currency

USD / EUR / /

/

Facility

Leiden University Medical Center / This pipeline / Broad Institute / Lung Diseases Institute / Windeyer Institute / University of Leuven / Institute of Medicine Report / University of Tartu / National Institute of Allergy / National Institute of Public Health / Karolinska Institute / University College London Medical School / University of Zaragoza / Max Planck Institute / Global Health Institute / UK Max Planck Institute / Turku University Hospital / Lausanne University / Central Institute / /

Holiday

New Year's Day / /

IndustryTerm

health services / healthcare delivery / healthcare providers / laboratory services / public health infrastructure / /

MedicalCondition

HIV / Drug-resistant tuberculosis / multidrug-resistant tuberculosis / Malaria / active TB / Allergy / diseases / HIV/AIDS / infection / infectious disease / extensively drug-resistant tuberculosis / sub-optimal infection / DF / TB / epidemic / lung disease / infections / XDR-TB / HIV infection / disease / ScienceDirect Tuberculosis / SARS / Mycobacterium tuberculosis / XDR / infectious diseases / Cough / Tuberculosis / /

Organization

Ecole Polytechnique Federale de Lausanne / World Health Organization / International Monetary Fund / United States Agency for International Development / European Academies Science Advisory Council / European Commission / European Union / Karolinska Institute / Stockholm / National Institute of Health / University College London Medical School / Leiden University / Germany German Academy of Sciences / Centre for Infectious Diseases and International Health / German Academy / University of Tartu / World Bank / Windeyer Institute / Lausanne University / Royal Society / UK Max Planck Institute for Infection Biology / /

Person

Alexander Indra / Roland Brosch / Volker / Stefan H. E. Kaufmann / Tuula Vasankari / Alan Altraja / Seung K. Stemming / George Kosmiadi / Van Deun / Maria Korzeniewska / Meulen / Staffan Normark / Alimuddin Zumla / Mario Raviglione (Observer) / Tom Ottenhoff / Stewart Cole / Carlos Martin / Robert Koch / Robin Fears / Brigitte Gicquel / Pascal van Bleyenbergh / Dick van Soolingen / Stefan Kaufmann / /

/

Position

President / tackle / Professor / Major / forward / Farmer / Corresponding author / leader / Chairman / Private / /

Product

kanamycin / isoniazid / rifampin / /

ProgrammingLanguage

EC / /

ProvinceOrState

Saskatchewan / EC / Maryland / /

PublishedMedium

PLoS ONE / /

Region

Baltic States / former Soviet Union / Eastern Europe / /

Technology

proteomics / diagnostic tests / genotyping / html / drug discovery / structural genomics / metabolomics / genomics / php / transcriptomics / pdf / drug development / /

URL

http /

SocialTag